New clues to why men are more likely to develop cancer than women. (US News & World Report)
Dutch oncologists and surgeons use titanium mandibles made from 3D images The first portrait of a mandibular implant head and neck cancer patient was performed. ( Netherlands Cancer Institute )
New recommendations to determine eligibility for lung cancer clinical trials could improve patients’ access to trials. (UT Southwestern, JAMA Oncology)
Targeting BCL-2 expression has shown promise to overcome resistance to CAR T-cell therapy in relapsed/refractory B-cell non-Hodgkin lymphoma. (Penn Medicine, Cancer Discovery)
Two NCI grants The study will investigate whether physical activity can reduce chemotherapy toxicity and increase its effectiveness. ( LSU Pennington Biomedical Research Center )
First CAR T cell therapy for multiple myeloma Bristol-Myers Squibb and 2seventy bio announced a randomized trial showing B-cell maturation antigen-targeted therapy idecabtagene viccleucel (Abecma) significantly improved progression-free survival compared with standard of care.
Daiichi Sankyo and AstraZeneca announce FDA approval of trastuzumab deruxtecan (Enhertu) for HER2 positive Resection/metastatic non-small cell lung cancer.
Smoking Cancer-related deaths in 2019 were associated with 2 million years of lost lives and $21 billion in lost income, according to a study by the American Cancer Society.
FDA Periodically Approves Capmatinib (Tabrecta) for the Treatment of Metastatic Non-Small Cells Associated with MET Exon 14 Skipping Lung cancer.
Bayer announces FDA approval of darolutamide (Nubeqa) plus docetaxel for the treatment of diversion
for ” Speculative comment,” GSK said in a statement, “GSK, the FDA, and the EMA [European Medicines Agency] have independently concluded that there is no evidence that ranitidine treatment is associated with cancer in patients. There is a causal relationship.”
-
Charles Bankhead is the Senior Editor for Oncology and also covers Urology, Dermatology and Ophthalmology. He joined MedPage today in 2007. focus on
